Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ACTRN12626000499381) titled 'MethoxyFLurane inhaler for single episode cancer-related incident pain in palliative cARE patients: The FLARE feasibility study' on April 22.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Primary Sponsor: Latrobe Regional Health
Condition:
Advanced cancer
Incidental Cancer Pain
Advanced cancer
Incidental Cancer Pain
Cancer - Any cancer
Intervention:
evaluating methoxyflurane as an acceptable alternative to standard care in managing single episode Incidental Cancer Pain in palliative care.
Each participant will be given one inhaler loaded with one dose (3 mL)...